ArticleVaccines2021

Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study.

Chin-Chou Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.